Apollo Hospitals Enterprise Limited (APOLLOHOSP) Revenue 2022–2026

Name: Apollo Hospitals Enterprise Limited (APOLLOHOSP) revenue history 2022-2026
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

DATA UPDATED 2026-09-20

Apollo Hospitals Enterprise Limited annual revenue for fiscal 2026 was ₹249.1 billion, an increase of 15.7% from ₹215.3 billion in fiscal 2025. All figures are reported results from public filings — no estimates or projections.

APOLLOHOSP Annual Revenue

Revenue (annual)	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Revenue	₹249.1B	₹215.3B	₹188.6B	₹164.4B	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

APOLLOHOSP Quarterly Revenue

Revenue (quarterly)	2026-06-30	2026-03-31	2025-12-31	2025-06-30	2025-03-31
Total Revenue	₹70.4B	₹66.1B	₹64.8B	₹58.4B	₹55.9B

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Revenue at Comparable Companies

MAXHEALTH Revenue — Max Healthcare Institute Limited
MANIPALHOS Revenue — Manipal Health Enterprises Limited
FORTIS Revenue — Fortis Healthcare Limited
ASTERDM Revenue — Aster DM Quality Care Limited
MEDANTA Revenue — Global Health Limited
NH Revenue — Narayana Hrudayalaya Limited

More APOLLOHOSP metrics: Gross Profit · Operating Income · Net Income · EPS · Free Cash Flow

All APOLLOHOSP financial statements → Interactive APOLLOHOSP charts →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.